Related Experiment Video
Updated: Apr 15, 2026
09:11
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
10.5K
Correction: Enzyme and voltage stimuli-responsive controlled release system based on β-cyclodextrin-capped mesoporous
1State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, China. huoqisheng@jlu.edu.cn.
Dalton Transactions (Cambridge, England : 2003)
|April 2, 2015
Summary
This correction clarifies a study on drug delivery systems. It addresses an error in the original publication concerning enzyme and voltage-responsive nanoparticles.
Area of Science:
- Materials Science
- Nanotechnology
- Chemical Engineering
Context:
- Controlled release systems are crucial for targeted drug delivery.
- Mesoporous silica nanoparticles offer high surface area for drug encapsulation.
- Stimuli-responsive systems enhance drug release precision.
Purpose:
- To correct an error in a previously published study.
- To ensure accurate representation of the enzyme and voltage-responsive controlled release system.
- To maintain scientific integrity and data reliability.
Summary:
- The correction pertains to a study detailing a drug delivery system using β-cyclodextrin-capped mesoporous silica nanoparticles.
- It addresses an inaccuracy within the original publication regarding the system's responsiveness to enzyme and voltage stimuli.
- This ensures the scientific community has correct information on the material's performance.
Impact:
- Ensures accurate understanding of stimuli-responsive nanomaterials for drug delivery.
- Maintains the reliability of research in nanotechnology and materials science.
- Facilitates correct future research and development based on validated data.
More Related Videos
Related Concept Videos
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
141
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
141
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
103
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
103
01:23Modified-Release Drug Delivery Systems: Classification
289
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
289
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
133
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
133
01:26Oral Drug Delivery Systems: Continuous-Release Systems
264
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
264
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
231
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
231